MHC class I chain-related protein A and B (MICA and MICB) are predominantly expressed intracellularly in tumour and normal tissueHormas Ghadially, Robert W. Wilkinson|British Journal of Cancer|2017Cited by 110
The MEK inhibitor selumetinib complements CTLA-4 blockade by reprogramming the tumor immune microenvironmentEdmund Poon, Robert W. Wilkinson|Journal for ImmunoTherapy of Cancer|2017Cited by 75